116 related articles for article (PubMed ID: 9930860)
1. Remembering MOG: autoantibody mediated demyelination in multiple sclerosis?
Wekerle H
Nat Med; 1999 Feb; 5(2):153-4. PubMed ID: 9930860
[No Abstract] [Full Text] [Related]
2. Identification of autoantibodies associated with myelin damage in multiple sclerosis.
Genain CP; Cannella B; Hauser SL; Raine CS
Nat Med; 1999 Feb; 5(2):170-5. PubMed ID: 9930864
[TBL] [Abstract][Full Text] [Related]
3. Determinant spreading associated with demyelination in a nonhuman primate model of multiple sclerosis.
McFarland HI; Lobito AA; Johnson MM; Nyswaner JT; Frank JA; Palardy GR; Tresser N; Genain CP; Mueller JP; Matis LA; Lenardo MJ
J Immunol; 1999 Feb; 162(4):2384-90. PubMed ID: 9973519
[TBL] [Abstract][Full Text] [Related]
4. Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response.
Stefferl A; Brehm U; Storch M; Lambracht-Washington D; Bourquin C; Wonigeit K; Lassmann H; Linington C
J Immunol; 1999 Jul; 163(1):40-9. PubMed ID: 10384097
[TBL] [Abstract][Full Text] [Related]
5. Studies of autoimmunity in multiple sclerosis.
Whitaker JN; Snyder DS
CRC Crit Rev Clin Neurobiol; 1984; 1(1):45-82. PubMed ID: 6400508
[TBL] [Abstract][Full Text] [Related]
6. Immunobiology of oligodendrocytes in multiple sclerosis.
Ruffini F; Chojnacki A; Weiss S; Antel JP
Adv Neurol; 2006; 98():47-63. PubMed ID: 16400826
[No Abstract] [Full Text] [Related]
7. Antibodies directed against rubella virus induce demyelination in aggregating rat brain cell cultures.
Besson Duvanel C; Honegger P; Matthieu JM
J Neurosci Res; 2001 Sep; 65(5):446-54. PubMed ID: 11536329
[TBL] [Abstract][Full Text] [Related]
8. To look for a needle in a haystack: the search for autoantibodies in multiple sclerosis.
Schirmer L; Srivastava R; Hemmer B
Mult Scler; 2014 Mar; 20(3):271-9. PubMed ID: 24589684
[TBL] [Abstract][Full Text] [Related]
9. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions.
Kerlero de Rosbo N; Hoffman M; Mendel I; Yust I; Kaye J; Bakimer R; Flechter S; Abramsky O; Milo R; Karni A; Ben-Nun A
Eur J Immunol; 1997 Nov; 27(11):3059-69. PubMed ID: 9394837
[TBL] [Abstract][Full Text] [Related]
10. Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study.
Lily O; Palace J; Vincent A
Brain; 2004 Feb; 127(Pt 2):269-79. PubMed ID: 14662514
[TBL] [Abstract][Full Text] [Related]
11. Demyelinating antibodies to myelin oligodendrocyte glycoprotein and galactocerebroside induce degradation of myelin basic protein in isolated human myelin.
Menon KK; Piddlesden SJ; Bernard CC
J Neurochem; 1997 Jul; 69(1):214-22. PubMed ID: 9202313
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to oligodendroglia in patients with multiple sclerosis.
Abramsky O; Lisak RP; Silberberg DH; Pleasure DE
N Engl J Med; 1977 Dec; 297(22):1207-11. PubMed ID: 335246
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis.
Dhib-Jalbut S
Neurology; 2007 May; 68(22 Suppl 3):S13-21; discussion S43-54. PubMed ID: 17548563
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55.
Ichikawa M; Johns TG; Liu J; Bernard CC
J Immunol; 1996 Jul; 157(2):919-26. PubMed ID: 8752946
[TBL] [Abstract][Full Text] [Related]
15. Skewed autoantibody reactivity to the extracellular domain of myelin oligodendrocyte glycoprotein in multiple sclerosis.
Tejada-Simon MV; Hong J; Rivera VM; Zhang JZ
Immunology; 2002 Dec; 107(4):403-10. PubMed ID: 12460184
[TBL] [Abstract][Full Text] [Related]
16. Immunopathogenic and clinical relevance of antibodies against myelin oligodendrocyte glycoprotein (MOG) in Multiple Sclerosis.
Berger T; Reindl M
J Neural Transm Suppl; 2000; (60):351-60. PubMed ID: 11205153
[TBL] [Abstract][Full Text] [Related]
17. Homogeneity of active demyelinating lesions in established multiple sclerosis.
Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
[TBL] [Abstract][Full Text] [Related]
18. Myelin peptides in multiple sclerosis.
Grau-López L; Raïch D; Ramo-Tello C; Naranjo-Gómez M; Dàvalos A; Pujol-Borrell R; Borràs FE; Martínez-Cáceres E
Autoimmun Rev; 2009 Jul; 8(8):650-3. PubMed ID: 19393199
[TBL] [Abstract][Full Text] [Related]
19. Neuropathology of multiple sclerosis-new concepts.
Kornek B; Lassmann H
Brain Res Bull; 2003 Aug; 61(3):321-6. PubMed ID: 12909302
[TBL] [Abstract][Full Text] [Related]
20. [The pathogenesis of multiple sclerosis. Cytotoxic antibodies against myelin sheath tissue in multiple sclerosis].
Frick E; Stickl H
Fortschr Med; 1976 Jun; 94(17):1019-24. PubMed ID: 964856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
